Effects of antibiotics upon quorum sening regulated characters: A propitious scheme against device associated infections

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue 3, 2014, Pages 85-90

  Rathinam, Prasanth ^a   Viswanathan, Pragasam ^a  

^a VIT UNIVERSITY   (India)

Author keywords

Catheter associated urinary tract infection; Cefuroxime; Quorum sensing inhibition; Sub inhibitory concentration

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; CEFUROXIME; CEPHALOSPORIN; COTRIMOXAZOLE; NALIDIXIC ACID; PYOCYANINE; PYOVERDINE; VIRULENCE FACTOR;

ARTICLE; BIOFILM; CATHETER ASSOCIATED URINARY TRACT INFECTION; CATHETER INFECTION; CELL DENSITY; CONTROLLED STUDY; GENE CONTROL; HUMAN; MINIMUM INHIBITORY CONCENTRATION; SPECTROFLUOROMETRY; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 84898434742     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Jahn P, Preuss M, Kernig A, Seifert HA and Langer G. Types of indwelling urinary catheters for long-term bladder drainage in adults. Cochrane Database Syst Rev. 2007; 18(3): CD004997.
2. Johnson JR, Delavari P and Azar M. Activities of a Nitrofurazone-Containing Urinary Catheter and a Silver Hydrogel Catheter against Multidrug-Resistant Bacteria Characteristic of Catheter-Associated Urinary Tract Infection. Antimicrob Agents Chemother. 1999; 43(12): 2990-5.
3. Falaqas ME and Makris GC. Probiotic bacteria and biosurfactants for nosocomial infection control: a hypothesis. J Hosp Infect. 2009; 71(4): 301-6.
4. Nicolle L. The chronic indwelling catheter and urinary infection in long-term-care facility residents. Infect Control Hosp Epidemiol. 2001; 22: 316-21.
5. Warren, J. Nosocomial urinary tract infections. In: Mandell G, Bennett J, Dolin R, editors. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone; 2000. p. 3028.
6. Warren J. Catheter-associated urinary tract infections. Infect Dis Clin North Am. 1997; 11: 609-22.
7. Tambyah P and Maki D. Catheter-associated urinary tract infection is rarely symptomatic. Arch Intern Med. 2000; 160: 678-82.
8. Gillespie W, Jones J, Teasdale C, Simpson R, Nashef L and Speller D. Does the addition of disinfectant to urine drainage bags prevent infection in catheterized patients? Lancet. 1983; 1: 1037-9.
9. Maizels M and Schaeffer AJ. Decreased incidence of bacteriuria associated with periodic instillations of hydrogen peroxide into the urethral catheter drainage bag. J Urol. 1980; 123: 841-5.
10. Pearman JW. The value of kanamycin-colistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord injury. Br J Urol. 1979; 51: 367-74.
11. Schaeffer AJ, Story KO and Johnson SM. Effect of silver oxide/trichloroisocyanuric acid antimicrobial urinary drainage system on catheter-associated bacteriuria. J Urol. 1988; 139: 69-73.
12. Saint S, Elmore JG, Sullivan SD, Emerson SS and Koepsell TD. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med. 1998; 105: 236-41.
13. Trauntner BW and Darouiche RO. Role of biofilm in catheter-associated urinary tract infection. Am J Infect Control. 2004; 32(3): 177-83.
14. Brosnahan J, Jull A and Tracy C. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev. 2004; (1): CD004013.
15. Maki DG and Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis. 2001; 7(2): 342-7.
16. Warren JW, Platt R, Thomas RJ, Rosner B and Kass EH. Antibiotic irrigation and catheter-associated urinary-tract infections. N Engl J Med. 1978; 299(11): 570-3.
17. Jarvis WR and Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother. 1992; 29: 19-24.
18. Denstedt J, Wollin T and Reid G. Biomaterials used in urology: current issues of biocompatibility, infection, and encrustation. J Endourol. 1998; 12: 493-500.
19. Clatworthy AE, Pierson E and Hung DT. Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol. 2007; 3(9): 541-8.
20. Miller MB and Bassler BL. Quorum sensing in bacteria. Annu Rev Microbiol. 2001; 55: 165-199.
21. Ganin H, Tang X and Meijler MM. Inhibition of Pseudomonas aeruginosa quorum sensing by AI-2 analogs. Bioorg Med Chem Lett. 2009; 19(14): 3941-4.
22. VanBogelen RA and Neidhardt FC. Ribosomes as sensors of heat and cold shock in Escherichia coli. Proc Natl Acad Sci USA. 1990; 87: 5589-5593.
23. Nalca Y, Jansch L, Bredenbruch F, Geffers R and Buer J, Haussler S. Quorum-Sensing Antagonistic Activities of Azithromycin in Pseudomonas aeruginosa PAO1: a Global Approach. Antimicrob Agents Chemother. 2006; 50(5): 1680-8.
24. Skindersoe ME, Alhede M, Phipps R, Yang L, Jensen PO, Rasmussen TB, et al. Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2008; 52(10): 3648-63.
25. Mittal R, Aggarwal S, Sharma S, Chhibber S and Harjai K. Urinary tract infections caused by Pseudomonas aeruginosa: a minireview. J Infect Public Health. 2009; 2(3): 101-11.
26. Gambello MJ and Iglewski BH. Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a tran scriptional activator of elastase expression. J Bacteriol. 1991; 173: 3000-9.
27. Ochsner UA and Reiser J. Autoinducer-mediated regulation of rhamnolipid biosurfactant synthesis in Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 1995; 92: 6424-8.
28. Witker M, Cockerill F, Craig W, Dudley M, Eliopoulos G, Hecht D et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard-seventh edition. Clinical and Laboratory Standards Institute document M7-A7. USA: Clinical and Laboratory Standards Institute. 2006.
29. Syed K, Bhagavathi M and Sivamaruthi S. Quorum Sensing Inhibition in Pseudomonas aeruginosa PAO1 by Antagonistic Compound Phenylacetic Acid. Curr Microbiol. 2012; 65(5): 475-80.
30. Cox CD and Adams P. Siderophore Activity of Pyoverdine for Pseudomonas aeruginosa. Infect Immun. 1985; 48(1):130-8.
31. Adonizio A, Kong KF and Mathee K. Inhibition of Quorum Sensing-Controlled Virulence Factor Production in Pseudomonas aeruginosa by South Florida Plant Extracts. Antimicrob Agents Chemother. 2008; 52(1): 198-203.
32. Packiavathy IA, Priya S, Pandian SK and Ravi AV. Inhibition of biofilm development of uropathogens by curcumin-An anti-quorum sensing agent from Curcuma longa. Food Chem. 2012; 148: 453-60.
33. Costerton J, Geesey G and Cheng K. How bacteria stick. Sci Am. 1978; 238: 86-95.
34. Costerton J, Lewandowski S, Caldwell D, Korber D, Lappin-Scott H. Microbial biofilms. Annu Rev Microbiol. 1995; 49: 711-45.
35. Nalca Y, Jansch L, Bredenbruch F, Geffers R, Buer J and Haussler S. Quorum-Sensing Antagonistic Activities of Azithromycin in Pseudomonas aeruginosa PAO1: a Global Approach. Antimicrob Agents Chemother. 2006; 50(5): 1680-8.
36. Defoirdt T, Boon N and Bossier P. Can bacteria evolve resistance to quorum sensing disruption?. PLoS Pathog. 2010; 6(7): e1000989.
37. Ciragil P and Söyletir G. Alginate, elastase and alkaline protease production of Pseudomonas aeruginosa strains isolated from various body sites. Mikrobiyol Bul. 2004; 38(4): 341-7.
38. Ohman DE, Cryz SJ and Iglewski BH. Isolation and Characterization of a Pseudomonas aeruginosa PAO Mutant That Produces Altered Elastase. J Bacteriol. 1980; 142(3): 836-42.
39. Clec'h C, Schwebel C, Français A, Toledano D, Fosse J-P, Garrouste-Orgeas M, et al., Does catheter-associated urinary tract infection increase mortality in critically ill patients? Infect Control Hosp Epidemiol. 2007; 28(12): 1367-73.
40. Skindersoe ME, Alhede M, Phipps R, Yang L, Jensen PO, Rasmussen TB, et al. Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2008; 52(10): 3648-63.
41. Wagner T, Soong G, Sokol S and Saiman L. Effects of Azithromycin on Clinical Isolates of Pseudomonas aeruginosa From Cystic Fibrosis Patients. Chest. 2005; 128(2): 912-9.
42. Ciofu O, Giwercman B, Pedersen SS and Høiby N. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of anti-pseudomonal treatment at the Danish CF Center. APMIS. 1994; 102(9): 674-80.
43. Davies J, Spiegelman GB and Yim G. The world of sub-inhibitory antibiotic concentrations. Curr Opin Microbiol. 2006; 9(5): 445-53.